New biomarker identifies uveal melanoma patients at high risk for metastasis

A study by J. William Harbour, M.D., associate director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues published today in Clinical Cancer Research details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail